Assessment of bone involvement by DXA and HR-pQCT in patients with X-linked hypophosphatemia
Journal of Bone and Mineral Metabolism · 2026-09 · 44 (5) · 634-645
DOI: 10.1007/s00774-026-01748-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bone and Mineral Metabolism, online erschienen am 11.08.2026. Verfasst von Iara Marcelino Sant Ana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione (IEDE), Rio de Janeiro, RJ, Brazil. iarasantanam@gmail.com. Hauptthemen laut MEDLINE: Familial Hypophosphatemic Rickets, Absorptiometry, Photon, Bone Density, Tomography, X-Ray Computed. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Federal Do Rio De Janeiro.
Abstract (Originalsprache)
Introduction
X-linked hypophosphatemic rickets (XLH) is a rare disease and its natural history affects the quality of life of patients, as it leads to bone deformities and architectural and qualitative changes in the bone. Materials and methods Sixteen XLH patients were selected from referral hospitals in Rio de Janeiro (12 women and four men) and compared to 16 healthy age- and sex-matched control individuals. All XLH were receiving calcitriol and oral phosphate supplements. Bone assessment was performed by high-resolution peripheral quantitative computed tomography (HR-pQCT) and dual-energy X-ray absorptiometry (DXA).
Results
XLH patients showed higher lumbar spine BMD Z-score, but lower 33% distal radius BMD and Z-score values as compared to control group. Low BMD for age (Z-score ≤ -2.0 SD) was only detected in the XLH group: specifically in 3 of the 5 postmenopausal women, 3 of the 7 premenopausal women, and 2 of the 4 men. HR-pQCT evaluation showed lower total vBMD at both peripheral sites and impaired trabecular parameters, particularly at the distal tibia, after correction for multiple comparisons.
Conclusion
Our study sheds light on the involvement of both trabecular and cortical compartments in the XLH group, despite conventional treatment. We also emphasize the limitation of DXA in assessing central sites in the XLH group. The 33% radius may represent a useful complementary skeletal site for DXA assessment, particularly when HR-pQCT is not available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione (IEDE), Rio de Janeiro, RJ, Brazil. iarasantanam@gmail.com.
- Division Endocrinology, Universidade Federal do Rio de Janeiro (UFRJ), Rua Professor Rodolpho Paulo Rocco, 255, Ilha do Fundão, Rio de Janeiro, RJ, 21941-617, Brazil. iarasantanam@gmail.com.
- Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil.
- Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione (IEDE), Rio de Janeiro, RJ, Brazil.
- Division Endocrinology, Universidade Federal do Rio de Janeiro (UFRJ), Rua Professor Rodolpho Paulo Rocco, 255, Ilha do Fundão, Rio de Janeiro, RJ, 21941-617, Brazil.
Förderung
- Universidade Federal Do Rio De Janeiro
Zitieren
APA
Sant Ana, I. M., Coelho, M. C. A., Cantoni, J., Kasuki, L., Farias, M. L. F., & Madeira, M. (2026). Assessment of bone involvement by DXA and HR-pQCT in patients with X-linked hypophosphatemia. Journal of Bone and Mineral Metabolism, 44(5), 634-645. https://doi.org/10.1007/s00774-026-01748-6
Vancouver
Sant Ana IM, Coelho MCA, Cantoni J, Kasuki L, Farias MLF, Madeira M. Assessment of bone involvement by DXA and HR-pQCT in patients with X-linked hypophosphatemia. Journal of Bone and Mineral Metabolism. 2026;44(5):634-645. doi:10.1007/s00774-026-01748-6
BibTeX
@article{SantAna2026,
author = {Sant Ana, Iara Marcelino and Coelho, Maria Caroline Alves and Cantoni, Joyce and Kasuki, Leandro and Farias, Maria Lucia Fleiuss and Madeira, Miguel},
title = {Assessment of bone involvement by DXA and HR-pQCT in patients with X-linked hypophosphatemia},
journal = {Journal of Bone and Mineral Metabolism},
year = {2026},
volume = {44},
number = {5},
pages = {634--645},
doi = {10.1007/s00774-026-01748-6}
}
EUVIMED